⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRN News
Amarin Corp Plc
Form 8-K
sec.gov
AMRN
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
globenewswire.com
AMRN
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer
globenewswire.com
AMRN
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
globenewswire.com
AMRN
Arevon Secures Three 20-Year Renewable Energy Credit Contracts for its 200 Megawatt Panther Energy Project in Illinois
prnewswire.com
AMRN
EXC
Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
globenewswire.com
AMRN
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO
HudsonLake Appoints Quinton Crenshaw as President, Elevates Executive Leadership Team as MikeWorldWide Integration Accelerates
prnewswire.com
AMRN
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
globenewswire.com
AMRN
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
globenewswire.com
AMRN